Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230040/S030

Cordella Pulmonary Artery Sensor System

Endotronix, Inc. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP230040/S030

What did the FDA approve?

The FDA record for P230040/S030 lists a normal 180-day track supplement with no user fee, dated October 29, 2026, for Endotronix, Inc.'s Cordella Pulmonary Artery Sensor System under product code MOM. The stated change is the addition of an alternate ethylene oxide (EO) gas sterilization facility, categorized as a location change affecting manufacturer, sterilizer, packager or supplier. Because the identifier links this to original PMA P230040, it is a supplement rather than a new approval of the whole system.

The record does not identify the new facility, its location, the sterilization cycle parameters, or any validation data. The stated purpose describes a manufacturing and sterilization-site addition only; it is not evidence of clinical safety or effectiveness of the device itself, and no such conclusion should be drawn from this notice.

FDA approval order statement

addition of alternate Ethyle Oxide (EO) gas sterilization facility
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P230040/S030
Regulatory pathway
PMA supplement
Product code
MOM
Decision code
APPR
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, hemodynamic, implantable.

Product code
MOM
FDA device class
3

For the original device and its historical approval scope, see PMA P230040. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P230040 · Original PMA

    Cordella Pulmonary Artery Sensor System (CorPASS)

  2. P230040/S030 received

    Application receipt date recorded by FDA.

  3. P230040/S033 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  4. P230040/S034 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  5. P230040/S031 · Related supplement

    Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)

  6. P230040/S035 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  7. P230040/S030 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230040

Product / regulatory recordCompanyPathwayDecision dateSource
Endotronix, Inc.PMA approvalJun 20, 2024FDA
Endotronix, Inc.PMA supplementSep 25, 2026FDA
Endotronix, Inc.PMA supplementOct 14, 2026FDA
Endotronix, Inc.PMA supplementOct 16, 2026FDA
Endotronix, Inc.PMA supplementOct 20, 2026FDA

Explore the linked device profile

Other records with product code MOM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Endotronix, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records